In this context, targeting enzymes like CROT, CRAT, CPT2, CPT1, and CAC, which regulate lipid transport and utilization, may inhibit cancer cell growth by disrupting their metabolic flexibility. The gene discussed is SLC25A20; the disease is cancer.